Pfizer sales fall as drugmaker races toward COVID-19 vaccine

The company's candidate vaccine to protect against Covid-19, which it is developing with BioNTech, began Phase 3 testing this week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.